Patent · US Active

Anti-TSG101 antibodies and their uses for treatment of viral infections

US7964708B2 · kind B2 · utility

0Cited by

26References

8Claims

0Family size

Inventors

Limin Li · Longbeilingcun, CN
Michael S. Kinch · Laytonsville, US
Michael Goldblatt · McLean, US
Roxanne Duan · Bethesda, US

Key dates

Filing date	Nov 15, 2007
Grant date	Jun 21, 2011
Priority date	—
Expiry date	Jan 26, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.